Ciclosporin - Polichem

Drug Profile

Ciclosporin - Polichem

Alternative Names: P-3072

Latest Information Update: 13 May 2016

Price : $50

At a glance

  • Originator Polichem
  • Class Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Neuroprotectants
  • Mechanism of Action Calcineurin inhibitors; Free radical inhibitors; Immunosuppressants; Mitochondrial permeability transition pore inhibitors; P-glycoprotein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Psoriasis

Most Recent Events

  • 13 May 2016 Chemical structure information added
  • 04 Mar 2016 Efficacy data from a phase II trial in Psoriasis presented at the 74th Annual Meeting of the American Academy of Dermatology (AAD- 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top